Partnership with ViBe 99.7FM to deploy AI-driven audio technology, aiming to revolutionize interactive advertising revenue for broadcasters.
Company raises long-term revenue and profit guidance, citing surging demand for its AI server infrastructure and enterprise IT solutions.
Zepzelca, in combination with Roche's Tecentriq, approved as first-line maintenance treatment for extensive-stage small cell lung cancer.
Regulator signals openness to an accelerated approval pathway for LX2006, a promising treatment for Friedreich's Ataxia cardiomyopathy.
High court rejects Google's appeal in Epic Games case, forcing an end to its mandatory 30% commission and setting a precedent that threatens Apple's lucrative model.
FDA grants Breakthrough Therapy Designation for the company's treatment of Sanfilippo Syndrome, a rare neurodegenerative disorder.
The multi-year partnership is expected to generate tens of billions in revenue, challenging Nvidia's market dominance.
FDA grants Breakthrough Therapy Designation to the company's drug for a rare, fatal pediatric disorder, paving the way for accelerated review and potential approval.